GAPP Italy: "A survey on asthma on Italian physicians and patients"

Guidelines recognize the importance of achieving and maintaining asthma control: the treatment strategies now available allow the control of the great majority of patients with asthma but despite many efforts only 5% of patients achieve guideline-defined asthma control. The GAPP (The Global Asthma P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fumagalli, Laura, Baena Cagnani, Rodrigo C., Compalati, Enrico, Braido, F., Canonica, Giorgio Walter, Baena Cagnani, Carlos E.
Formato: Artículo PeerReviewed
Lenguaje:Español
Publicado: European Annals of Allergy and Clinical Immunology 2010
Materias:
Acceso en línea:http://pa.bibdigital.ucc.edu.ar/4977/1/A_Fumagalli.pdf
Aporte de:
id I38-R144-4977
record_format dspace
spelling I38-R144-49772025-11-03T14:42:52Z http://pa.bibdigital.ucc.edu.ar/4977/ GAPP Italy: "A survey on asthma on Italian physicians and patients" Fumagalli, Laura Baena Cagnani, Rodrigo C. Compalati, Enrico Braido, F. Canonica, Giorgio Walter Baena Cagnani, Carlos E. R Medicina (General) Guidelines recognize the importance of achieving and maintaining asthma control: the treatment strategies now available allow the control of the great majority of patients with asthma but despite many efforts only 5% of patients achieve guideline-defined asthma control. The GAPP (The Global Asthma Physician and Patient survey) is a global quantitative survey with the aim of identifying barriers to optimal management of asthma. Physicians and adult patients with persistent asthma have been interviewed with closed-ended questions questionnaire. This study has been conducted in 16 countries. In Italy the survey has revealed that physicians prescribe a combination of ICS and LABA more often in the other countries. They consider ICS the first-line treatment for mild persistent asthma. They are not completely satisfied with ICS because of local and systemic side effects. At the same time, the reason why patients change asthma medication is the potential for side effects. The two group responses were found to differ about the time spent discussing how to improve the management of asthma. A better communication between physician and patient and a new treatment option with lower side effect profile could be the key point to achieve asthma control in a larger number of patients. European Annals of Allergy and Clinical Immunology 2010-12-31 Artículo PeerReviewed application/pdf spa http://pa.bibdigital.ucc.edu.ar/4977/1/A_Fumagalli.pdf Fumagalli, Laura, Baena Cagnani, Rodrigo C., Compalati, Enrico ORCID: https://orcid.org/0000-0002-1856-6139 <https://orcid.org/0000-0002-1856-6139>, Braido, F., Canonica, Giorgio Walter ORCID: https://orcid.org/0000-0001-8467-2557 <https://orcid.org/0000-0001-8467-2557> and Baena Cagnani, Carlos E. (2010) GAPP Italy: "A survey on asthma on Italian physicians and patients". European Annals of Allergy and Clinical Immunology, 42 (4). pp. 146-154. ISSN 03979148
institution Universidad Católica de Córdoba
institution_str I-38
repository_str R-144
collection Producción Académica Universidad Católica de Córdoba (UCCor)
language Español
orig_language_str_mv spa
topic R Medicina (General)
spellingShingle R Medicina (General)
Fumagalli, Laura
Baena Cagnani, Rodrigo C.
Compalati, Enrico
Braido, F.
Canonica, Giorgio Walter
Baena Cagnani, Carlos E.
GAPP Italy: "A survey on asthma on Italian physicians and patients"
topic_facet R Medicina (General)
description Guidelines recognize the importance of achieving and maintaining asthma control: the treatment strategies now available allow the control of the great majority of patients with asthma but despite many efforts only 5% of patients achieve guideline-defined asthma control. The GAPP (The Global Asthma Physician and Patient survey) is a global quantitative survey with the aim of identifying barriers to optimal management of asthma. Physicians and adult patients with persistent asthma have been interviewed with closed-ended questions questionnaire. This study has been conducted in 16 countries. In Italy the survey has revealed that physicians prescribe a combination of ICS and LABA more often in the other countries. They consider ICS the first-line treatment for mild persistent asthma. They are not completely satisfied with ICS because of local and systemic side effects. At the same time, the reason why patients change asthma medication is the potential for side effects. The two group responses were found to differ about the time spent discussing how to improve the management of asthma. A better communication between physician and patient and a new treatment option with lower side effect profile could be the key point to achieve asthma control in a larger number of patients.
format Artículo
PeerReviewed
author Fumagalli, Laura
Baena Cagnani, Rodrigo C.
Compalati, Enrico
Braido, F.
Canonica, Giorgio Walter
Baena Cagnani, Carlos E.
author_facet Fumagalli, Laura
Baena Cagnani, Rodrigo C.
Compalati, Enrico
Braido, F.
Canonica, Giorgio Walter
Baena Cagnani, Carlos E.
author_sort Fumagalli, Laura
title GAPP Italy: "A survey on asthma on Italian physicians and patients"
title_short GAPP Italy: "A survey on asthma on Italian physicians and patients"
title_full GAPP Italy: "A survey on asthma on Italian physicians and patients"
title_fullStr GAPP Italy: "A survey on asthma on Italian physicians and patients"
title_full_unstemmed GAPP Italy: "A survey on asthma on Italian physicians and patients"
title_sort gapp italy: "a survey on asthma on italian physicians and patients"
publisher European Annals of Allergy and Clinical Immunology
publishDate 2010
url http://pa.bibdigital.ucc.edu.ar/4977/1/A_Fumagalli.pdf
work_keys_str_mv AT fumagallilaura gappitalyasurveyonasthmaonitalianphysiciansandpatients
AT baenacagnanirodrigoc gappitalyasurveyonasthmaonitalianphysiciansandpatients
AT compalatienrico gappitalyasurveyonasthmaonitalianphysiciansandpatients
AT braidof gappitalyasurveyonasthmaonitalianphysiciansandpatients
AT canonicagiorgiowalter gappitalyasurveyonasthmaonitalianphysiciansandpatients
AT baenacagnanicarlose gappitalyasurveyonasthmaonitalianphysiciansandpatients
_version_ 1848831216945463296